None listed
Conditions
Interventions
None listed
Sponsors
Nagoya University Hospital
Flatiron Health K.K.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria will be included in this study: 1. Patients who received care at Nagoya University Hospital between January 1, 2011 and December 31, 2028 2. Patients with a confirmed diagnosis of any of the following tumor types: - Breast cancer - Thoracic malignancy (non-small cell lung cancer, small cell lung cancer,etc) - Gastrointestinal cancer (pancreatic cancer, liver cancer) 3. Patients aged 18 and above 4. Patient(or a legal surrogate) has either confirmed willingness to participate in the study through one of the following methods, or has not expressed a decline to participate. - Written informed consent has been obtained using study-specific explanatory and consent documents. - For eligible patients who visited the Nagoya University Hospital on or after January 1, 2011, and are already deceased, no objection to participation has been received from the patient's legal surrogate after being provided with an opportunity to decline participation in this study,provided that this does not contradict the explicit wishes expressed by the patient during their lifetime. Surrogate: Spouse, parents, siblings, children/grandchildren, grandparents, relatives living together with the subject patient, or persons considered to be equivalent to such close relatives (excluding minors).
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Real-world overall survival, time-to-next-treatment, progression-free survival, time-to-treatment-discontinuation etc. | — |
Countries
Japan
Contacts
Public ContactToyone Kikumori
Nagoya University Hospital Breast and Endocrine Surgery Department
Outcome results
None listed